These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33755319)

  • 1. Deficiency of cold-inducible RNA-binding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1.
    Liu J; Ke X; Wang L; Zhang Y; Yang J
    J Cell Mol Med; 2021 May; 25(10):4732-4743. PubMed ID: 33755319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against monocrotaline-induced pulmonary arterial hypertension and caveolin-1 downregulation by fluvastatin in rats.
    Zhu S; Wang J; Wang X; Zhao J
    Mol Med Rep; 2018 Mar; 17(3):3944-3950. PubMed ID: 29286128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-181a/b-5p ameliorates inflammatory response in monocrotaline-induced pulmonary arterial hypertension by targeting endocan.
    Zhao H; Guo Y; Sun Y; Zhang N; Wang X
    J Cell Physiol; 2020 May; 235(5):4422-4433. PubMed ID: 31637717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
    Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
    Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1.
    Zhao H; Wang Y; Zhang X; Guo Y; Wang X
    Toxicol Appl Pharmacol; 2020 Jan; 386():114827. PubMed ID: 31734320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin-(1-7) improves endothelium-dependent vasodilation in rats with monocrotaline-induced pulmonary arterial hypertension].
    Liu XX; Chen AD; Pan Y; Zhang F; Qi ZB; Cao N; Han Y
    Sheng Li Xue Bao; 2023 Aug; 75(4):497-502. PubMed ID: 37583036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
    Qin T; Kong B; Dai C; Xiao Z; Fang J; Shuai W; Huang H
    Bioengineered; 2022 Feb; 13(2):2697-2709. PubMed ID: 35042435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.
    Li F; Wang D; Wang H; Chen L; Sun X; Wan Y
    Respir Res; 2021 Aug; 22(1):239. PubMed ID: 34465322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of vesicular transport proteins in pulmonary arterial hypertension in monocrotaline-treated rats.
    Zhang H; Luo Q; Liu Z; Wang Y; Zhao Z
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):156-63. PubMed ID: 25630652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
    Nakazawa H; Hori M; Ozaki H; Karaki H
    Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyl diphosphate synthase regulated endothelial proliferation and autophagy during rat pulmonary arterial hypertension induced by monocrotaline.
    Jin T; Lu J; Lv Q; Gong Y; Feng Z; Ying H; Wang M; Fu G; Jiang D
    Mol Med; 2022 Aug; 28(1):94. PubMed ID: 35962329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of m
    Zeng Y; Huang T; Zuo W; Wang D; Xie Y; Wang X; Xiao Z; Chen Z; Liu Q; Liu N; Xiao Y
    Aging (Albany NY); 2021 Jul; 13(14):18238-18256. PubMed ID: 34310344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension.
    Mathew R; Huang J; Shah M; Patel K; Gewitz M; Sehgal PB
    Circulation; 2004 Sep; 110(11):1499-506. PubMed ID: 15353500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
    Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
    Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
    Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corno C; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Endocrinol Invest; 2019 Aug; 42(8):951-965. PubMed ID: 30674010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension.
    Huang J; Kaminski PM; Edwards JG; Yeh A; Wolin MS; Frishman WH; Gewitz MH; Mathew R
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1250-9. PubMed ID: 18390833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
    Pan LC; Wilson DW; Segall HJ
    Toxicology; 1993 Mar; 79(1):21-35. PubMed ID: 8475497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.